Niki BioSolutions, Inc.
NIKIEarnings History
| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Mar 27, 2026 | $-4.20 | — | — | — |
| Oct 8, 2025 | $-0.62 | — | — | — |
| Dec 20, 2024 | $-5.00 | — | — | — |
| Apr 30, 2024 | $51.00 | $-27.00 | — | $1.3M |
| Dec 22, 2023 | $-14.30 | $-26.00 | $431.4K | $1.0M |
| Apr 28, 2023 | $-2.22 | $-0.26 | $768.4K | $800.0K |
| Sep 30, 2022 | $-5.30 | — | $527.5K | — |
| Apr 29, 2022 | $-2.52 | $-0.33 | $904.0K | $700.0K |
News
NYSDOH CLEP approval extends validated APOE genotyping beyond blood, buccal swab, saliva, and tissue for clinical and research use
Agreement brings CAP and NYS CLEP-approved genotyping test to a multi-site Alzheimer's clinical research network PRINCETON, NJ, NEW HAVEN, CT and ORLANDO, FL, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc. (NASDAQ: NIKI), a life sciences company focused on addressing unmet medical needs through advanced genomic and biomarker testing, today announced that DiamiR Biosciences, its wholly owned subsidiary, has signed an agreement to perform apolipoprotein E (APOE) genotyping for Charter R…
Company's blood-based microRNA biomarker panel is designed to support monitoring of disease progression and treatment response in Rett syndrome
Plasma-based APOE genotyping to add genetic risk data to a diverse, deeply characterized Alzheimer's biomarker cohort PRINCETON, N.J., and NEW HAVEN, Conn.
NEW HAVEN, CT and PRINCETON, NJ, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc. (NASDAQ: NIKI), a life sciences company focused on addressing unmet medical needs and providing high-quality genomic and biomarker testing solutions, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026.
Advanced multi-omics data analysis and biostatistical expertise to sharpen target and biomarker decisions across the platform
Live company presentation will take place on September 14 at 10:30 AM ET NEW HAVEN, CT and PRINCETON, NJ, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Niki BioSolutions, Inc. (NASDAQ: NIKI), a life sciences company focused on addressing unmet medical needs and providing high-quality genomic and biomarker testing solutions, today announced that it will participate in the 28th Annual H.C.